
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Triple Inhaled Therapy in COPD: Current Guidelines, Benefits/Risks, and ETHOS Trial Discussion
By
National Jewish Health
FEATURING
James P. Woodrow
By
National Jewish Health
FEATURING
James P. Woodrow
5,038 views
August 12, 2021
James Woodrow, MD, of National Jewish Health, discusses the article “Triple Inhaled Therapy at Two ...
read more ↘ Glucocorticoid Doses in Moderate to Very Severe COPD” during the 30-minute inaugural webinar of the COPD Journal Club on August 3, 2021.
View the Article Summary:
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate to Very Severe COPD (ETHOS Trial) N England J Med 2020; 383:35-48.
https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/copd-article-summary-triple-therapy_vol1_issue1.aspx
↖ read less
read more ↘ Glucocorticoid Doses in Moderate to Very Severe COPD” during the 30-minute inaugural webinar of the COPD Journal Club on August 3, 2021.
View the Article Summary:
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate to Very Severe COPD (ETHOS Trial) N England J Med 2020; 383:35-48.
https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/copd-article-summary-triple-therapy_vol1_issue1.aspx
↖ read less
Comments 1
Login to view comments.
Click here to Login